Osteoarthritis management options in general practice by Mckenzie, Suzanne & Torkington, Amanda
FOCUS Joint pain
Background
Osteoarthritis, characterised by joint pain and stiffness, is a 
common and significant chronic disease, reducing mobility 
and causing considerable impact on quality of life. Multiple 
evidence based management options are available.
Objective
The aim of this article is to summarise the main 
management options suggested in The Royal Australian 
College of General Practitioners Guideline for the non-
surgical management of hip and knee osteoarthritis and to 
also highlight those that are not recommended. 
Discussion
Following diagnosis based primarily on history and 
examination, management focuses on optimising quality 
of life by providing self management advice combined 
with appropriate pharmacological and nonpharmacological 
strategies, aiming to reduce acute exacerbations, prevent 
complications and delay progression.
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Osteoarthritis (OA) is a significant chronic disease and 
a common presentation in general practice. Over 50% of 
people over the age of 65 years have radiological evidence 
of disease and approximately 10% of men and 18% of 
women have symptomatic OA.1 Joint pain and reduced 
mobility cause considerable impact on quality of life. With 
no current cure for this condition, general practitioners 
are left with a range of management options aimed at 
optimising quality of life and self management, preventing 
acute episodes, delaying complications and preventing 
progression of the condition. 
To assist the GP in deciding which of the many possible 
pharmacological and nonpharmacological options to recommend to 
their patients, The Royal Australian College of General Practitioners 
(RACGP) published the Guideline for the non-surgical management 
of hip and knee osteoarthritis in 2009.2 While the recommendations 
in this guideline focus on the hip and knee, many of the 
recommendations are relevant to OA in other sites. 
Diagnosing osteoarthritis
Diagnosis is usually based on patient history and examination. 
Weight bearing radiographs may be used to confirm the diagnosis but 
the findings are often nonspecific. Features suggestive of OA include:
•	 increased	age
•	 symmetrical	joint	pain	and	stiffness
•	 decreased	joint	mobility
•	 joint	swelling,	and	
•	 crepitus.	
Alternative	causes	of	joint	pain	should	be	considered	and	excluded.2
 As the prevalence of OA increases with age, it is often associated 
with comorbidities. The assessment of a patient with OA should 
therefore focus not only on the musculoskeletal system but also 
include assessment of obesity (a risk factor for both development and 
progression of OA)3,4 and other conditions that may impact on the 
management of OA. These conditions are outlined in Table 1.
Management of osteoarthritis
As OA is a chronic condition the management should focus both on 
proactive and reactive care. Planned care provides a structure to:
•	 optimise	quality	of	life
•	 encourage	and	support	self	management
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•	 manage	acute	episodes
•	 prevent	or	delay	complications,	and	
•	 prevent	progression.7
The importance of multidisciplinary care and goal setting in this 
context is emphasised in the guidelines. The development of a 
management plan (Table 2) should be tailored to the individual patient’s 
circumstances and preferences, as well as the evidence of effectiveness 
for specific interventions. multidisciplinary collaboration allows the 
patient to access the broad range of nonpharmacological interventions 
used in OA treatment. These can be provided by healthcare providers 
such as physiotherapists, occupational therapists, massage and manual 
therapists, personal trainers, exercise physiologists, dieticians and 
nurses. Providers involved in pharmacological management include GPs, 
pharmacists, rheumatologists, and orthopaedic surgeons. seeking care 
from an appropriately trained provider is a component of effective and 
safe therapy.8
 A practice nurse or allied health professional can provide 
valuable assistance across a range of areas when considering a care 
plan. They can assist with patient assessment and documentation; 
provision of patient education and self management support; 
preparation of the plan, contacting appropriate services, referral 
and review, advising the patient about likely expenses, facilitating 
communication between providers, and providing copies to all 
involved (including the patient).
Optimising quality of life
nonpharmacological therapies should form the basis of management, 
with the aim of decreasing pain and improving function for all patients. 
evidence supports assisting all patients to achieve optimal weight 
by at least two of the following methods: nutritional education, 
cognitive behaviour therapy, low energy diet and exercise (either 
land	based	exercises	and/or	aquatic	therapy	for	patients	with	OA).3,9 
exercise provides benefit even if weight loss is not achieved or 
required,	and	has	a	role	in	both	symptom	management	and	as	a	
preventive strategy. Patients may prefer organised instruction when 
using exercise to manage OA.10 Patients who believe that exercise 
is	harmful	to	their	joints	are	less	likely	to	participate	in	exercise,11 
so specific advice to exercise alongside education about the benefits 
and appropriate referral by GPs may assist in overcoming this barrier 
to exercise participation. Referral using initiatives such as team 
care arrangements12 may reduce financial barriers to allied health 
involvement. While weight reduction and exercise have the strongest 
supportive evidence, allied health interventions are not only limited to 
these modalities.
 There is some evidence to support the use of multimodal physical 
therapy (which includes a range of different therapeutic strategies 
and usually incorporates manual therapy such as muscle stretching 
and passive range of movement strategies), tai chi, thermotherapy 
(cold therapy), transcutaneous electrical nerve stimulation (Tens) and 
acupuncture. Weak evidence suggests that patellar taping, massage 
therapy, low level laser therapy, magnetic bracelets and leech therapy 
may be of some benefit.2
Table 1. Conditions impacting on  
osteoarthritis
•	 Cognitive	impairment
•	 Cardiovascular	disease
•	 Peptic	ulcer	disease
•	 Renal	disease
•	 Diabetes
•	 Asthma
•	 Allergies
•	 Liver	disease
•	 	Depression	and	anxiety	(more	common	in	patients	
with chronic conditions)
•	 Falls	risk	
•	 	Medications	(especially	polypharmacy	and	potential	
drug interactions)3–6
Table 2. Example of GP Management Plan for OA2
Patient, carer and GP details
Assessment: date, site and severity of weight bearing X-ray, 
body mass index, waist circumference, number of falls in past 
12 months
Past medical history, family history, medications (note any self 
management issues), allergies
Patient’s concerns, actions, importance, support and review 
date:
Education/self management
Self management course and written information
GP/practice nurse, physiotherapist, Arthritis Association
Pain and stiffness
Know more about how to manage this better
GP, physiotherapist, support group, pharmacist, rheumatologist
Weight
Healthy lifestyle and weight loss advice
GP, dietician, physiotherapist, exercise physiologist
Mood
How does OA impact on mood and how to manage this
GP, practice nurse, psychologist, partner/carer
Impact on daily activities
Learning	how	to	make	these	easier
GP, occupational therapist
Medications
Most appropriate medications; improved understanding of 
actions and side effects
GP, pharmacist, Home Medicines Review
Managing flare-ups
Self management such as rest, ice packs, creams; increase 
pain medications; see GP
GP, nurse, physiotherapist, rheumatologist
Review date: 3–6 months
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and other languages) and also runs self management courses via local 
organisations in each state and territory. 
 Regular follow up and discussion about arthritis can improve 
symptoms via monitoring of recommended therapies and providing 
important social and self management support.5 An individual’s 
social situation and psychological state play an important part in 
pain perception. Patients with lower education levels or concurrent 
depression are more likely to perceive troublesome pain.18 social, 
environmental and psychological interventions may be appropriate 
depending on the patient’s individual needs.
Managing acute episodes
Acute episodes can be managed by a stepwise approach to both 
pharmacological and nonpharmacological management. This involves 
adding pharmacological agents above the patient’s baseline therapy. 
For example, for the patient on regular paracetamol at maximum 
recommended dosage, addition of short term topical therapy or  
oral nonsteroidal anti-inflammatory drugs (nsAiDs) should be 
considered (Table 3).
	 Intra-articular	injection	of	corticosteroid	provides	rapid	relief	for	
approximately 4 weeks and is a useful strategy for those patients in 
whom oral nsAiDs are either not tolerated or are contraindicated. 
Repeated	injections	appear	to	be	less	useful.5 it is recommended 
that	GPs	performing	intra-articular	injections	receive	training	in	the	
procedure.2
 local ice-packs and rest are appropriate initial nonpharmacological 
therapies for acute flares, as is appropriate referral for other therapy 
such as physiotherapy.
Preventing or delaying complications and 
progression
lifestyle modification plays an important role in both the prevention 
and management of OA. being overweight increases the risk of 
 braces and orthoses, electromagnetic fields and therapeutic 
ultrasound provide no additional benefit above placebo, and are 
therefore not recommended.2
 The choice of pharmacological intervention should be guided by 
severity of symptoms, their impact on function and risk assessment.5 
Pharmacotherapy can be tailored according to disease severity 
and symptom response (Table 3). simple analgesia is the basis of 
pharmacotherapy; if indicated by symptoms, other agents should be 
added to the regimen, with follow up to assess for effectiveness. 
Patients are not always aware of the place that long term regular 
paracetamol plays in the management of OA,13 so education by GPs 
may improve adherence. Aiming for the fewest agents possible to 
achieve the desired symptom control will reduce potential risks.5
 Patients will often want to try glucosamine products or other agents 
such as vitamins or herbs. There is conflicting evidence about the 
benefit of glucosamine products in the treatment of symptoms. Vitamins, 
herbs and other dietary therapies are of limited or no benefit in treating 
OA of the hip or knee2 (see the article by marie Pirotta on the use of 
complementary therapies in arthritic disease in this issue).
	 Those	patients	whose	symptoms	are	not	adequately	controlled	
despite appropriate conservative therapy should be assessed for 
surgery: the RACGP has developed a tool to assist GPs assess patients 
for	joint	replacement	surgery.14–16
 many patients with severe pain from OA do not consult their GP 
about their pain, despite visiting them about other health matters.17 
Opportunities	to	optimise	quality	of	life	and	prevent	progression	may	
therefore be missed unless GPs adopt a strategy of opportunistically 
enquiring	about	pain	and	function	in	all	patients	with	OA.
Supporting self management
Patients with OA should be provided with information about their 
condition and advised about appropriate support groups. Arthritis 
Australia (see Resources) provides a range of online resources (english 
Table 3. Pharmacological therapy in osteoarthritis
Mild to moderate persistent symptoms Moderate to severe persistent symptoms
Simple analgesia Regular paracetamol (maximum 4 g/day)
Topical therapy Short	term	NSAIDs	or	capsaicin
Oral	NSAIDs Trial short term after assessment of risk; monitor blood pressure and renal function; for patients 
at high risk add a proton pump inhibitor or prescribe a COX-2 inhibitor6
Viscosupplementation 
(knee only)
Synthetic hyaluronic acid or hylan products 
via intra-articular injection. No benefit for hip 
osteoarthritis
Opioid therapy Consider for severe symptoms if surgery 
contraindicated or delayed; commence at low 
dose, titrate dose and monitor for adverse 
events
Intra-articular 
corticosteroid injection
Acute	flare	of	symptoms	when	trial	of	NSAIDs	contraindicated	or	not	effective
Other agents Role of glucosamine hydrochloride and glucosamine sulphate remains uncertain; chondroitin 
sulphate no clear evidence of benefit; vitamin, herbal and other dietary therapies of little or no benefit
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progression of OA, and evidence suggests that weight reduction 
reduces disability in patients with OA.2 exercise has a place in 
preventing progression and complications of OA as a component of 
weight management by improving general health and by preventing the 
development of functional disability, particularly in knee OA.3
 Current evidence does not support a role for glucosamine or 
chondroitin in prevention of cartilage loss in OA.2
 As discussed, GPs are well placed to provide long term care in 
patients with OA, including diagnosis, patient education and support, 
provision of pharmacological and nonpharmacological therapies and 
appropriate referral. Regular follow up of patients with established 
OA, including ongoing patient education, review of multidisciplinary 
care, medication review and behavioural modification, can reduce the 
risk of disease progression as well as prevent complications in at risk 
populations, including falls risk in the elderly.
Summary of important points
•	 Symptom	severity	should	guide	appropriate	management.
•	 Develop	a	goal	setting	care	plan	based	on	need,	evidence	for	
effectiveness and patient preferences.
•	 Involve	a	multidisciplinary	team	in	management.
•	 Promote	and	support	patient	self	management.
Resources
•	 Arthritis	Australia:	www.arthritisaustralia.com.au
•	 National	Prescribing	Service:	www.nps.org.au
•	 The	RACGP:	www.racgp.org.au
•	 Therapeutic	Guidelines:	www.tg.com.au.
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